RENAL CELL CARCINOMA (RCC)
Clinical trials for RENAL CELL CARCINOMA (RCC) explained in plain language.
Never miss a new study
Get alerted when new RENAL CELL CARCINOMA (RCC) trials appear
Sign up with your email to follow new studies for RENAL CELL CARCINOMA (RCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Kidney cancer drug combo shows promise but trial stopped early
Disease control TerminatedThis study tested two drugs (toripalimab and lenvatinib) given before and after kidney cancer surgery in 17 people with different stages of kidney cancer. The goal was to see if the drugs could shrink or eliminate the tumor before surgery. The trial was stopped early, so results …
Matched conditions: RENAL CELL CARCINOMA (RCC)
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated May 26, 2026 08:19 UTC
-
Can two diabetes drugs shield kidneys after cancer surgery?
Disease control TerminatedThis study looked at whether two drugs, finerenone and empagliflozin (used alone or together), could slow kidney function decline in people at high risk for chronic kidney disease after having a kidney removed for cancer. Ten participants took the drugs or no drug for one year, w…
Matched conditions: RENAL CELL CARCINOMA (RCC)
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated May 22, 2026 14:04 UTC